Crude Medicine Ingredients for Research and Experimental Use
COUNTRY OF ORIGIN
Japan
APPLICATION
trans-Ferulic Acid: A Hydroxylcinnamic Acid with Antioxidant Activity
trans-Ferulic acid is a hydroxylcinnamic acid with antioxidant activity1) that is present as compounds bound to carbohydrate in the cell walls of plants,2) including Angelica acutiloba Kitagawa which is an important crude drug in Kampo medicines (traditional Japanese medicine).,3) Furthermore, its antioxidant activity has been shown to act synergistically with vitamins C and E.4,5) (The product is for research purpose only.)
P264 : Wash skin thoroughly after handling.
P280 : Wear protective gloves/ eye protection/ face protection.
P337 + P313 : If eye irritation persists: Get medical advice/ attention.
P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P302 + P352 : IF ON SKIN: Wash with plenty of soap and water.
P332 + P313 : If skin irritation occurs: Get medical advice/ attention.
P362 : Take off contaminated clothing and wash before reuse.
RTECS
GD9275000
MERCK ID
4062.0
*USAGE / SAFETY STATEMENT
For laboratory research and development purposes only.
PURITY
>98.0%(GC)(T)
PHYSICAL FORM
Solid
MWCO (kDa)
194.19
QUALITY CERTIFICATION / COMPLIANCE
Fukaya factory is certified for GMP, ISO14001:2004 (JQA-EM5386) and IQ Net (JP-JQA-EM5386).
APPEARANCE
White to Orange to Green powder to crystal
MOLECULAR FORMULA
C10H10O4
SDBS (AIST SPECTRAL DB)
31771.0
HS NUMBER
2918.29.7500
PURITY / ANALYSIS METHOD
>98.0%(GC)(T)
Questions & Answers (0)
Citations (0)
Shipping & Handling
Shipped In
Ambient
Safety & Storage
Storage Temperature
See product label for specific storage conditions.
Safety Statement
For laboratory research and development purposes only.
Regulatory & Compliance
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.